Literature DB >> 9710214

Human T cell IgD receptors react with O-glycans on both human IgD and IgA1.

C D Swenson1, T Patel, R B Parekh, S M Tamma, R F Coico, G J Thorbecke, A R Amin.   

Abstract

Previous studies on murine T cell IgD-R have shown that these receptors recognize N-glycans of murine IgD, and not of other Ig isotypes. We have now studied the specificity of IgD-R on human T cells. Human IgD digested with proteinase K to fragments of < 5 kDa inhibit the ability of T cells to form rosettes with IgD-coated ox erythrocytes. The same amount of digested IgG does not. We tested all the human Ig isotypes: IgG1, -2, -3, -4, IgA2, IgE and IgM fail to inhibit significantly at 20 microg/assay. However, IgA1 is as effective as IgD itself, showing approximately 60 % and 80 % inhibition at 5 microg and 10 microg/assay. Human IgA1 and IgD both contain Gal-1 --> 3-GalNac-rich O-linked glycans, and on this basis are both bound to ricin and jacalin. The O-linked glycans may therefore also represent the common moiety binding to IgD-R. Disaccharides Gal-1 --> 3-GalNac, and Gal-1 --> 4-Glc at 10 microg/assay blocked IgD rosetting while Gal-1 --> 6-Glc did not. We conclude that the human IgD-R is a lectin, differing from the murine IgD-R in that it has both IgA1 and IgD as ligands.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9710214     DOI: 10.1002/(SICI)1521-4141(199808)28:08<2366::AID-IMMU2366>3.0.CO;2-D

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  9 in total

Review 1.  New insights into the enigma of immunoglobulin D.

Authors:  Kang Chen; Andrea Cerutti
Journal:  Immunol Rev       Date:  2010-09       Impact factor: 12.988

Review 2.  Rethinking mucosal antibody responses: IgM, IgG and IgD join IgA.

Authors:  Kang Chen; Giuliana Magri; Emilie K Grasset; Andrea Cerutti
Journal:  Nat Rev Immunol       Date:  2020-02-03       Impact factor: 53.106

Review 3.  The function and regulation of immunoglobulin D.

Authors:  Kang Chen; Andrea Cerutti
Journal:  Curr Opin Immunol       Date:  2011-02-24       Impact factor: 7.486

4.  Secreted IgD Amplifies Humoral T Helper 2 Cell Responses by Binding Basophils via Galectin-9 and CD44.

Authors:  Meimei Shan; Jorge Carrillo; Ada Yeste; Cindy Gutzeit; Daniel Segura-Garzón; A Cooper Walland; Marc Pybus; Emilie K Grasset; John R Yeiser; Dean B Matthews; Willem van de Veen; Laura Comerma; Bing He; Tadech Boonpiyathad; Haekyung Lee; Julià Blanco; Lisa C Osborne; Mark C Siracusa; Mübeccel Akdis; David Artis; Saurabh Mehandru; Hugh A Sampson; M Cecilia Berin; Kang Chen; Andrea Cerutti
Journal:  Immunity       Date:  2018-10-02       Impact factor: 31.745

5.  Expressional analysis of immunoglobulin D in cattle (Bos taurus), a large domesticated ungulate.

Authors:  Beilei Xu; Jing Wang; Min Zhang; Ping Wang; Zhiguo Wei; Yi Sun; Qiqing Tao; Liming Ren; Xiaoxiang Hu; Ying Guo; Jing Fei; Lei Zhang; Ning Li; Yaofeng Zhao
Journal:  PLoS One       Date:  2012-09-13       Impact factor: 3.240

Review 6.  The Tn antigen-structural simplicity and biological complexity.

Authors:  Tongzhong Ju; Vivianne I Otto; Richard D Cummings
Journal:  Angew Chem Int Ed Engl       Date:  2011-01-21       Impact factor: 15.336

7.  Abnormal IgD and IgA1 O-glycosylation in hyperimmunoglobulinaemia D and periodic fever syndrome.

Authors:  Jacob F de Wolff; Stephen J Dickinson; Alice C Smith; Karen Molyneux; John Feehally; Anna Simon; Jonathan Barratt
Journal:  Clin Exp Med       Date:  2009-06-20       Impact factor: 3.984

8.  B Cell IgD Deletion Prevents Alveolar Bone Loss Following Murine Oral Infection.

Authors:  Pamela J Baker; Nicole Ryan Boutaugh; Michaela Tiffany; Derry C Roopenian
Journal:  Interdiscip Perspect Infect Dis       Date:  2009-10-25

9.  The effects of Antibody Engineering CH and CL in Trastuzumab and Pertuzumab recombinant models: Impact on antibody production and antigen-binding.

Authors:  Wai-Heng Lua; Wei-Li Ling; Joshua Yi Yeo; Jun-Jie Poh; David Philip Lane; Samuel Ken-En Gan
Journal:  Sci Rep       Date:  2018-01-15       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.